BDBM480005 3-(tert-butyl)-N-(2-methyl-4-(4-((1-methyl-1H-pyrazol-3-yl)amino)-1,3,5-triazin-2-yl)benzyl)-1,2,4-oxadiazole-5-carboxamide ::US10899753, Example 2

SMILES Cc1cc(ccc1CNC(=O)c1nc(no1)C(C)(C)C)-c1ncnc(Nc2ccn(C)n2)n1

InChI Key InChIKey=ZQYSDZVPMRTACC-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 480005   

TargetTyrosine-protein kinase BTK(Human)
Biogen Ma

US Patent
LigandPNGBDBM480005(3-(tert-butyl)-N-(2-methyl-4-(4-((1-methyl-1H-pyra...)
Affinity DataIC50: 1nMAssay Description:The purpose of the BTK in vitro assay is to determine compound potency against BTK through the measurement of IC50. Compound inhibition is measured a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
Go to US Patent